LH down-regulates gonadotropin-releasing hormone (GnRH) receptor, but not GnRH, mRNA levels in the rat testis

• Published in: Journal of endocrinology Vol. 162; no. 3; pp. 409 - 415
• Main Authors: Botte, MC, Lerrant, Y, Lozach, A, Berault, A, Counis, R, Kottler, ML
• Format: Journal Article
• Language: English
• Published: Colchester BioScientifica 01.09.1999; Portland Press
• Subjects: Analysis of Variance; Animals; Biological and medical sciences; Chorionic Gonadotropin - pharmacology; Fundamental and applied biological sciences. Psychology; Gonadotropin-Releasing Hormone - agonists; Gonadotropin-Releasing Hormone - antagonists & inhibitors; Gonadotropin-Releasing Hormone - genetics; Hormone metabolism and regulation; Immunoblotting; Luteinizing Hormone - pharmacology; Male; Mammalian male genital system; Oligopeptides - pharmacology; Rats; Rats, Wistar; Receptors, LHRH - genetics; Receptors, LHRH - metabolism; RNA, Messenger - analysis; RNA, Messenger - metabolism; Testis - drug effects; Testis - metabolism; Testosterone - pharmacology; Triptorelin Pamoate - pharmacology; Vertebrates: reproduction; Rat; Rodentia; Gonadotropin RH; Gonadotropin; Gene expression; Testicle; Male genital system; Hypothalamic hormone; Vertebrata; Mammalia; Adenohypophyseal hormone; Hormonal regulation; Luteinizing hormone; Steroidogenesis; Hormone releasing factor; Hormonal receptor
• ISSN: 0022-0795; 1479-6805
• DOI: 10.1677/joe.0.1620409

The demonstration of an inhibitory effect of gonadotropin-releasing hormone (GnRH) agonists upon steroidogenesis in hypophysectomized rats and the presence of mRNA coding for GnRH and GnRH receptors (GnRH-R) in rat gonads suggests that GnRH can act locally in the gonads. To assess this hypothesis, we investigated the effects of GnRH analogs, gonadotropins and testosterone on the levels of both GnRH and GnRH-R mRNA in the rat testis. Using dot blot hybridization, we measured the mRNA levels 2 to 120 h after the administration of the GnRH agonist, triptorelin. We observed an acute reduction of both GnRH and GnRH-R mRNAs 24 h after the injection (about 38% of control). However, the kinetics for testis GnRH-R mRNA were different from those previously found for pituitary GnRH-R mRNA under the same conditions. Initially, the concentrations of serum LH and FSH peaked, then declined, probably due to the desensitization of the gonadotrope cells. In contrast, the GnRH antagonist, antarelix, after 8 h induced a 2.5-fold increase in GnRH-R mRNA, but not in GnRH mRNA, while gonadotropins levels were reduced. Human recombinant FSH had no significant effect on either GnRH or GnRH-R mRNA levels. Inversely, GnRH-R mRNA levels markedly decreased by 21% of that of control 24 h after hCG injection. Finally, 24 h after testosterone injection, a significant increase in GnRH-R mRNA levels (2.3 fold vs control) was found, but a reduction in the concentration of serum LH, probably by negative feedback on the pituitary, was observed. In contrast, GnRH mRNA levels were not significantly altered following testosterone treatment. Since LH receptors, GnRH-R and testosterone synthesis are colocalized in Leydig cells, our data suggest that LH could inhibit the GnRH-R gene expression or decrease the GnRH-R mRNA stability in the testis. However, this does not exclude the possibility that GnRH analogs could also affect the GnRH-R mRNA levels via direct binding to testicular GnRH-R. In contrast, the regulation of GnRH mRNA levels appeared to be independent of gonadotropins. Taken together, our results suggest a regulation of GnRH and GnRH-R mRNA specific for the testis.